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α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors are comprised of
different combinations of GluA1–GluA4 (also known as GluR1–GluR4 and GluR-A to GluR-D)
subunits. The GluA2 subunit is subject to RNA editing by the ADAR2 enzyme, which con-
verts a codon for glutamine (Gln; Q), present in the GluA2 gene, to a codon for arginine
(Arg; R) found in the mRNA. AMPA receptors are calcium (Ca2+)-permeable if they contain
the unedited GluA2(Q) subunit or if they lack the GluA2 subunit.While most AMPA recep-
tors in the brain contain the edited GluA2(R) subunit and are therefore Ca2+-impermeable,
recent evidence suggests that Ca2+-permeable AMPA receptors are important in synaptic
plasticity, learning, and disease. Strong evidence supports the notion that Ca2+-permeable
AMPA receptors are usually GluA2-lacking AMPA receptors, with little evidence to date
for a signiﬁcant role of unedited GluA2 in normal brain function. However, recent detailed
studies suggest that Ca2+-permeable AMPA receptors containing unedited GluA2 do in
fact occur in neurons and can contribute to excitotoxic cell loss, even where it was previ-
ously thought that there was no unedited GluA2.This review provides an update on the role
of GluA2 RNA editing in the healthy and diseased brain and summarizes recent insights
into the mechanisms that control this process.We suggest that further studies of the role
of unedited GluA2 in normal brain function and disease are warranted, and that GluA2 edit-
ing should be considered as a possible contributing factor when Ca2+-permeable AMPA
receptors are observed.
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INTRODUCTION
The release of the neurotransmitter glutamate from presynaptic
densities activates postsynaptic glutamate-gated ion channels in-
cluding α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors, N-methyl D-aspartate (NMDA) receptors and
kainate (KA) receptors. Once activated, the glutamate-gated ion
channels ﬂux sodium (Na+) and in some cases will also ﬂux cal-
cium (Ca2+). NMDA receptors are uniformly Ca2+-permeable,
with well-recognized roles in synaptic plasticity and disease. Most
AMPA receptors and some KA receptors are Ca2+-impermeable,
however Ca2+-permeable AMPA receptors (Jia et al., 1996; Lamsa
et al., 2007) and KA receptors (Vissel et al., 2001; Lerma, 2003;
Sun et al., 2009) also exist at some synapses where they can
play a role in synaptic plasticity and disease (Gorter et al., 1997;
Pellegrini-Giampietro et al., 1997; Liu and Zukin, 2007). This
review focuses on the critical role of glutamine/arginine (Q/R) site
RNA editing of the GluA2 subunit in regulating AMPA receptor
Ca2+-permeability.
AMPA receptors are tetrameric assemblies of different combi-
nations of four subunits designated GluA1–GluA4 (alternatively
known asGluR1–GluR4 andGluR-A toGluR-D; reviewed inHoll-
mann and Heinemann, 1994; Dingledine et al., 1999; Sobolevsky
et al., 2009). The Ca2+-permeability of AMPA receptors varies
depending on whether the GluA2 subunit is present within
the tetramer. The ability of the GluA2 subunit to regulate
Ca2+-permeability of AMPA receptors in turn depends on RNA
editing. RNA editing is a post-transcriptional modiﬁcation that
alters a codon encoding glutamine (Gln; Q) to a codon encod-
ing arginine (Arg; R) in the GluA2 mRNA. AMPA receptors
are Ca2+-impermeable if they contain the edited GluA2(R) sub-
unit. Conversely, AMPA receptors are Ca2+-permeable if they
are GluA2-lacking or if they contain the unedited GluA2(Q)
subunit.
Studies to date provide strong evidence that GluA2-lacking
AMPA receptors contribute to normal brain function and disease
(Pellegrini-Giampietro et al., 1997; Isaac et al., 2007; Wiltgen et al.,
2010; Man, 2011). Additional to this, almost no unedited RNA
exists in the brain; less than 1% of all RNA on average across the
gray matter of the brain encodes unedited GluA2(Q) (Kawahara
et al., 2003). Taken together, the evidence has largely been accepted
to suggest that unedited GluA2 does not play a major role in brain
function and disease. More recently, however, sophisticated stud-
ies have revealed a possible role for unedited GluA2 in regulating
excitotoxic neuronal cell death in ischemia and ALS (reviewed in
Kwak and Kawahara, 2005; Kwak and Weiss, 2006; Liu and Zukin,
2007; Kwak et al., 2010). This is perhaps surprising given many
earlier studies previously ruled out a role for unedited GluA2 in
ischemia (Akbarian et al., 1995; Rump et al., 1996; Kortenbruck
et al., 2001). These recent studies demonstrate that whilst only
∼1% GluA2 RNA is unedited on average across the brain, it can
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vary substantially from cell-to-cell reaching much higher levels
in some individual cells. Thus unedited GluA2 RNA is difﬁcult
to detect. This raises the possibility of an as-yet undetected role
for unedited GluA2 in speciﬁc aspects of physiology and in other
diseases.
The original discovery of AMPA receptor RNA editing estab-
lished the critical implications of this type of post-transcriptional
modiﬁcation to genes. As such, RNA editing has now been exten-
sively investigated throughout the mammalian genome (Mattick
and Mehler, 2008). In this review,we will explore the role of GluA2
RNA editing and outline new insights into the mechanisms that
control this process. We will further discuss the role of GluA2-
lacking receptors and GluA2 unedited receptors and suggest that
understanding the role of unedited GluA2(Q) containing recep-
tors, and the mechanisms that regulate RNA editing, will become
increasingly important for understanding normal brain function
and excitotoxic cell death. We propose that, despite the low
FIGURE 1 | Schematic view of AMPA, NMDA, and KA receptors within
the postsynaptic density and the AMPA receptor structure. (A) Glutamate
in the synaptic cleft can act on ionotropic receptors including AMPA, NMDA,
and KA receptors causing a Ca2+ inﬂux leading to intracellular signaling
cascades. (B) Representation of the primary structure of AMPA receptor
subunits with N- and C-terminals, four membranes, M1–M4 (gray boxes), two
editing sites, Q/R and R/G (violet dots), and alternate spliced ﬂip/ﬂop site
(violet box). A summary of glutamate receptors and their subunits are also
shown. Subunits shown in violet are subunits that undergo RNA editing at the
Q/R site. (C)Topology (secondary structure) of the GluA2 subunit with three
transmembrane domains. The Q/R RNA editing site controls
Ca2+-permeability of the AMPA receptor site and is located in the putative
second membrane domain. The R/G site and ﬂip/ﬂop sites, which control
desensitization of the receptor, are located prior to the fourth membrane
domain. The protein sequence of GluA2 varies by one codon, arginine (Arg),
from GluA1, GluA3, and GluA4, which express a glutamine (Gln). The arginine
is post-transcriptionally introduced by an amino acid change in the pre-mRNA
of GluA2 by RNA editing. (D) Current response in normal Ringer solution and
Ca2+-Ringer solution of oocytes injected with GluA1 cRNA (left) or
GluA1+GluA2 cRNA (right). Oocytes containing GluA2 eliminated the inward
current, thus showing GluA2 regulates Ca2+-permeability of the AMPA
receptor. Reprinted from Hollmann et al. (1991), with permission.
percentage of unedited GluR2 mRNA present in the brain, it is not
yet possible to rule out a critical, and substantial, role of unedited
GluA2 in health and disease.
THE GluA2 SUBUNIT OF THE AMPA RECEPTOR PLAYS
A KEY ROLE IN NORMAL CENTRAL NERVOUS SYSTEM
FUNCTION
Glutamate, the major excitatory neurotransmitter in the central
nervous system (CNS), activates AMPA, NMDA, and KA recep-
tors and can potentially cause inﬂux of Ca2+ into the postsynaptic
density (Figure 1A). Conventionally, NMDA receptors were con-
sidered to be the primary glutamate receptor involved in synaptic
plasticity and Ca2+-mediated excitotoxic cell death in the healthy
and diseased brain, respectively. However, abundant evidence now
suggests that Ca2+-permeable AMPA receptors are also involved
in synaptic plasticity (Malinow and Malenka, 2002; Cull-Candy
et al., 2006; Isaac et al., 2007; Liu and Zukin, 2007), play a role in
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memory and learning (Riedel et al., 1999;Wiltgen et al., 2010), and
contribute to excitotoxic cell loss in disease (Pellegrini-Giampietro
et al., 1997; Tanaka et al., 2000; Kwak and Weiss, 2006).
SUBUNIT COMPOSITION DETERMINES AMPA RECEPTOR PROPERTIES
AND CHARACTERISTICS
The four subunits of AMPA receptors, GluA1–GluA4, share
68–73% sequence identity. Each subunit consists of a large extra-
cellular N-terminus domain, an intracellular C-domain and three
transmembrane domains (M1, M3, and M4; Figure 1B). The
putative second membrane domain (M2) consists of a hairpin
structure, which changes direction within the membrane and
returns to the intracellular side of the cell (Figure 1C). Each sub-
unit exists in two forms created by alternative splicing, termed
“ﬂop” and “ﬂip,” which is an interchangeable sequence consisting
of 38-amino acids found prior to the fourth membrane domain.
Each form is expressed preferentially in different regions of the
brain (Hollmann and Heinemann, 1994). The kinetic properties
of the AMPA receptors are regulated by the splice variants of the
subunits. For example, the ﬂop variants of GluA2–GluA4 desen-
sitize faster than ﬂip variants, but recover more slowly (Sommer
et al., 1990). On the other hand,GluA1ﬂip andﬂop variants desen-
sitize at equal rates depending on the concentration of glutamate
(Mosbacher et al., 1994). Within the hippocampus and cerebral
neocortex, the majority of AMPA receptors contain GluA2, which
predominantly forms heteromers with GluA1 (Wenthold et al.,
1996; Greger et al., 2002). Lower levels of GluA3 and GluA4 are
expressed in these areas (Wenthold et al., 1996). In the absence of
the GluA2 subunit,AMPA receptors often consist of GluA1/GluA3
hetero-oligomers, which may lead to reduced expression of the
AMPA receptor at the synapse (Sans et al., 2003).
THE GluA2 SUBUNIT REGULATES CALCIUM PERMEABILITY AND
TRAFFICKING OF AMPA RECEPTORS
The ability of Ca2+ to enter the cell through the AMPA receptor is
determined by the GluA2 subunit, which is preferentially incorpo-
rated into the receptor (Sans et al., 2003). When AMPA receptors
are assembled from combinations of GluA1, GluA3, and GluA4
the receptors are highly permeable toCa2+. However, whenGluA2
is contained within the AMPA receptor, the Ca2+-permeability is
profoundly decreased (Figure 1D; Hollmann et al., 1991). Thus,
since the vast majority of AMPA receptors are hetero-oligomers
consisting of GluA1/GluA2 or GluA2/GluA3 subunits, they are
Ca2+-impermeable (Wenthold et al., 1996).
The subunit composition of AMPA receptors is important as
it affects not only Ca2+-permeability, but also the trafﬁcking of
the receptors (Malinow and Malenka, 2002). AMPA receptors are
assembled in the endoplasmic reticulum (ER) and are trafﬁcked
to the plasma membrane and their presence at the synapse is in a
dynamic equilibrium between insertion (exocytosis) and removal
(endocytosis; Malinow and Malenka, 2002; Keifer and Zheng,
2010; Man, 2011). The presence of the GluA2 subunit is impor-
tant for the stability and trafﬁcking of AMPA receptors within the
synapse, though it is not essential (Biou et al., 2008; Panicker et al.,
2008). The C-terminus of GluA2 binds with, among other pro-
teins, N-ethylmaleimide-sensitive factor (NSF), an ATPase, which
is involved in the insertion of the AMPA receptor into the synapse
and synaptic activation of the receptor (reviewed in Bassani et al.,
2009). In fact, A synchrony of complex intracellular mechanisms
drives AMPA receptor trafﬁcking (Ziff, 2007; Kessels and Mali-
now, 2009; Jackson and Nicoll, 2011). As we shall discuss, GluA2
RNA editing at the Q/R site can also regulate trafﬁcking (discussed
in Section “GluA2 RNA Editing has a Role in AMPA Receptor
Trafﬁcking”).
THE IMPORTANCE OF GluA2 IN THE TETRAMERIC ASSEMBLY OF THE
AMPA RECEPTOR
As we note above, AMPA receptors are generally considered to
be tetramer assemblies of various combinations of GluA1–GluA4
(Rosenmund et al., 1998; Nakagawa, 2010). The GluA1–GluA4
subunits consist of an extracellular amino-terminal domain,which
is involved in receptor assembly and trafﬁcking, a ligand bind-
ing domain and a transmembrane domain, which form the ion
channel (Figure 2A). GluA2 subunit assembly begins with the
formation of dimers in which the amino-terminal and trans-
membrane terminal domain segments are coupled. Sobolevsky
et al. (2009) have been able to determine the structure of ele-
ments of the GluA2 AMPA receptor ion channel tetramer, using
X-ray diffraction data. Their study reveled the receptor has a
twofold axis of molecular symmetry and within the ion channel
domain there is a fourfold axis of rotational symmetry (Sobolevsky
et al., 2009).
The crystal structure does not as-yet fully resolve the gate or
the Q/R site within the membrane. However it is known that
tetrameric assemblies of GluA1–GluA4 subunits form a large pore
with a diameter of approximately 0.78 nm (Burnashev et al., 1996).
When GluA2 is present within the receptor, the Q/R site is located
within the cytoplasmic side of the channel pore, immediately
below the transmembrane central cavity (Sobolevsky et al., 2009).
Interestingly, the amino acid residue present at the Q/R site does
not affect the diameter of the pore. When Gln is present, a negative
electrostatic potential is formed with the N-terminus of the M2
loop and thus attracts cations. However, the replacement of the
neutral Gln with a large positively charged Arg residue neutralizes
this potential and thus prevents the diffusion of divalent cations
through the channel (Kuner et al., 2001). It is still unclear, however,
how many Arg are required to prevent cation diffusion. This raises
the question of how anywhere from one to fourArg’s present at the
membrane pore can become selective for Na+ over Ca2+. Further
studies are required to determine why the process of RNA editing
at only one subunit can dramatically alter the Ca2+-permeability
of the receptor, while four GluA2(R) subunits can also have exactly
the same effect.
DISCOVERY OF GluA2 RNA EDITING AND ITS NECESSITY FOR AMPA
RECEPTOR FUNCTION
TheHeinemanngroupwas the ﬁrst to show that theGluA2 subunit
is an essential role determinant of theCa2+-permeability of AMPA
receptors (Hollmann et al., 1991; Hume et al., 1991). The investi-
gators further showed that the effect of GluA2 on AMPA receptor
Ca2+-permeability results from a single amino acid present at
position 607 in GluA2 mRNA (Figure 1C). Speciﬁcally, they dis-
covered that GluA2 mRNA encodes an Arg at position 607, while
the equivalent position in GluA1, GluA3, and GluA4 subunit
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FIGURE 2 | AMPA receptors containing GluA2 are Ca2+-impermeable due
to editing at the Q/R site. (A) Current understanding of the quaternary
structure of AMPA receptors, thought to be tetrameric assemblies of four
AMPA receptor subunits form the ion channel pore. The assembled receptor
can comprise any combination of GluA1–GluA4 subunits but usually contains
GluA2. Reprinted from Sobolevsky et al. (2009), with permission. (B) AMPA
receptors generally contain GluA2 (red) with combinations of GluA1, GluA3,
and GluA4 (blue). AMPA receptors containing edited GluA2 are impermeable
to Ca2+ (left). AMPA receptors containing unedited GluA2 and AMPA
receptors lacking GluA2 are Ca2+-permeable (right).
mRNA encodes a Gln. The investigators used site-directed muta-
genesis to alter the Arg in GluA2 mRNA to a Gln, as found in the
other subunits (Hume et al., 1991). They showed that GluA2(Q)
subunits self assembled into functional Ca2+-permeable AMPA
receptors while GluA2(R) subunits self assembled into AMPA
receptors with low Ca2+-permeability (Hume et al., 1991). Thus,
these studies established categorically that the Arg at position
607 of GluA2 is the critical determinant of AMPA receptor
Ca2+-permeability.
It was later discovered, somewhat remarkably, by Sommer et al.
(1991) in Seeburg’s group, that the Arg at position 607 is in fact
not encoded in the DNA but is introduced post-transcriptionally.
The investigators found that the codon encoding the critical Arg at
position 607 was present in the GluA2 cDNA, however the GluA2
gene DNA sequence at this position encoded a Gln (Sommer et al.,
1991). They then showed through a series of elegant studies that
the codon for Arg is introduced into the mRNA by RNA edit-
ing. Speciﬁcally, RNA editing converts an adenosine (A) in the
critical CAG codon (encoding Gln) found in the pre-mRNA to
an inosine (I), which creates a CIG codon (encoding Arg) in the
mRNA (Melcher et al., 1996). Since ribosomes read the inosine as a
guanosine (G), the editing effectively alters theCAGcodon (encod-
ing Gln) to a CGG codon (encoding Arg). The resulting edited
GluA2(R) subunit prevents Ca2+ inﬂux when it is incorporated
in the AMPA receptor. Conversely, AMPA receptors containing
unedited GluA2(Q) are highly permeable to Ca2+ (summarized
in Figure 2B). Unedited GluA2 at the Q/R site can cause AMPA
receptor-mediated excitotoxicity, a process we shall discuss later in
this review.
Notably, GluA2 RNA editing at the Q/R site occurs in ∼99% of
cases where GluA2 is present. The editing process is reliant upon
an intronic sequence called the editing complementary sequence
(ECS), which is located in intron 11 downstream of the editing
site (Higuchi et al., 1993). This ECS forms a dsRNA structure
with the editing site in the pre-mRNA. The primary RNA editing
enzyme, adenosine deaminase acting on RNA (ADAR), identi-
ﬁes this dsRNA structure and alters the CAG codon encoding
Gln to a CIG codon encoding Arg, though it is still unclear
how this site recognition occurs (Dabiri et al., 1996). Currently,
three ADAR family members have been identiﬁed (ADAR1–3),
in which ADAR2 is the primary modiﬁer of the GluA2Q/R site
(Melcher et al., 1996; Bass, 2002). All three ADARs are preferen-
tially expressed in the nervous system. Interestingly, ADAR3 is
exclusively expressed in the brain, however its function remains
unknown and it may play a regulatory role in RNA editing (Chen
et al., 2000).
ADAR2 also edits GluA2 at amino acid position 764, which
alters a codon for Arg to a glycine codon (R/G site). The R/G
editing site, but not the Q/R site, is also found in GluA3 and
GluA4. The R/G site, along with the ﬂip/ﬂop, is involved in desen-
sitization and recovery of the receptor, though is not involved in
Ca2+-permeability. Receptors containing GluA2 edited at the R/G
site are able to recover from desensitization more rapidly than
receptors containing unedited GluA2 at the R/G site. Interestingly,
despite this site also being edited by ADAR2, approximately only
90% of RNA is edited at the R/G site of GluA2, and this is lower
during development (Lomeli et al., 1994). Both the Q/R site and
the R/G site are regulated by ADAR2, yet the extent of editing
appears to be regulated differentially between the two sites. It is
still unclear as to how and why developmental regulation at the
R/G site occurs. However, it appears that currently unidentiﬁed
mechanisms differentially regulate editing at the Q/R and R/G
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sites. It remains to be determined if glutamate signaling regulates
editing in someway, similar to serotonin regulation of RNAediting
of the 5-HT 2C RNA (Burns et al., 1997).
There have been extensive efforts to identify RNA editing sites
in the mammalian genome since the discovery of GluA2 RNA
editing (Bass, 2002; Mattick and Mehler, 2008). RNA editing
was observed early on in the GluK1 and GluK2 subunits of KA
receptors, but has so far not been found to occur in NMDA recep-
tors. Recent studies have provided evidence of extensive editing
throughout the mammalian genome (Mattick and Mehler, 2008).
A summary of editing sites in glutamate receptors is shown in
Table 1.
CHARACTERISTICS OF CALCIUM-PERMEABLE AMPA RECEPTORS
AMPA receptors can be Ca2+-permeable because they are GluA2-
lacking or because they contain the unedited GluA2(Q) subunit.
Ca2+-permeable AMPA receptors can be detected by Ca2+ imag-
ing, but more often than not these receptors are detected using
electrophysiology. Unfortunately, however, current techniques
are unable to differentiate between GluA2-lacking receptors and
AMPA receptors containing unedited GluA2 at the synapse.
AMPA receptors have the same characteristics whether they are
GluA2-lacking or whether they contain the unedited GluA2(Q)
subunit: First, they areCa2+-permeable. Second, theAMPA recep-
tors exhibit inward rectiﬁcation (decreased conductance of AMPA
receptors’ synaptic currents’ potentials from positive to 0 mV)
when the polyamine, spermine, is diffused into the cell from the
recording electrode; this is measured as an altered rectiﬁcation
index. Third, Ca2+-permeable AMPA receptors become selec-
tively sensitive to block by Joro spider toxin (JSTX) and to related
drugs such as 1-naphthylacetyl spermine (NAS) and IEM-1460.
Sometimes these changes are also associated with AMPA receptor-
mediated synaptic transmission being enhanced, which is detected
as an increased ratio of AMPA/NMDA receptor-mediated synaptic
currents.
While Ca2+ permeable AMPA receptors can be identiﬁed by
electrophysiology, it is not possible, by any currently available
Table 1 | Summary of ionotropic glutamate receptor editing sites and
their effects.
Receptor Subunit Site Editing Consequence
AMPA GluA2 Q/R site M2 A → I ↓Ca2+-permeability
↓Conductance
↓Spermine block
↓Blockade by toxins
GluA2,3,4 R/G site between A → I ↑Recovery from
M3 and M4 desensitization
Kainate GluK1,2 Q/R site M2 A → I ↓Ca2+-permeability
↓Conductance
↓Spermine block
↓Blockade by toxins
GluK2 I/V site M1 A → I ↓Ca2+-permeability
Y/C site M1
methods to directly distinguish GluA2-lacking AMPA receptors
from AMPA receptors containing unedited GluA2 subunits.
Unedited GluA2 is, at present, only identiﬁed by analyzing RNA
from speciﬁc cells or brain regions using one of three methods:
(1) A “primer extension” assay (Schiffer and Heinemann, 1999;
Vissel et al., 2001), (2) DNA sequencing (which measures the ratio
of edited G nucleotide peak to unedited A nucleotide peak in
total cDNA; Maas et al., 2001), and (3) restriction enzyme based
assays,usually using the enzymeBbvI (Kawahara et al., 2004a; Peng
et al., 2006).
Theonlyway to infer the presence of functional uneditedGluA2
containing AMPA receptors is to combine electrophysiology with
an RNA editing assay. In general, this has been achieved by study-
ing neurons with patch clamp electrophysiology to demonstrate
the presence of Ca2+-permeable AMPA receptors. Following this,
the nucleus is extracted into the patch electrode and the RNA
is isolated. Single cell PCR is performed in combination with an
editing assay to demonstrate the percentage of edited and unedited
GluA2 mRNA within the cell (Peng et al., 2006). If unedited GluA2
mRNA is found to be present concurrently with Ca2+-permeable
AMPA receptors it suggests that AMPA receptors contain unedited
GluA2 at the synapse. Conversely, if the RNA in a cell does not con-
tain unedited GluA2 then it can be inferred that Ca2+-permeable
receptors are GluA2-lacking.
In most studies, however, rarely are editing analyses carried out
when Ca2+-permeable AMPA receptors are observed at synapses.
Since GluA2 is almost 100% edited in the normal brain, it is gener-
ally assumed that unedited GluA2 does not play a signiﬁcant role
in normal brain function. Therefore, while AMPA receptors lack-
ing GluA2 and AMPA receptors containing unedited GluA2 show
similar properties, the appearance of Ca2+-permeable AMPA
receptors at synapses – usually detected by electrophysiology –
is generally interpreted to mean the GluA2-lacking AMPA recep-
tor has been inserted at the synapse, rather than AMPA receptors
containing unedited GluA2.
It remains a critical problem that it is difﬁcult to differenti-
ate edited GluA2(R) protein from unedited GluA2(Q) protein
at synapses. Many studies have shown that in circumstances
where Ca2+-permeable AMPA receptors exist, GluA2 expression
is reduced relative to expression of GluA1. This is consistent
with the notion that the observed AMPA receptors are Ca2+-
permeable because they are GluA2-lacking. However, this does
not experimentally rule out that GluA2 unedited receptors may
also be present and contribute to Ca2+-permeability in paral-
lel to GluA2-lacking receptors. For example, as we shall discuss,
GluA2-lacking receptors have been observed and implicated in
the excitotoxic cell loss following brain ischemia (Pellegrini-
Giampietro et al., 1992; Calderone et al., 2003). More recently it
was found that unedited GluA2 also occurs in ischemia and that
this is critical to the excitotoxic neurodegeneration that follows
(Peng et al., 2006). Consequently recent data suggests that the
Ca2+-permeable receptors following ischemia result at least in
part from unedited GluA2. This leaves open a largely unexplored
possibility that in other scenarios where Ca2+-permeable recep-
tors are observed, unedited GluA2 may play an as-yet unidentiﬁed
role, even though previous evidence suggests such receptors are
GluA2-lacking.
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TO DATE, GluA2-LACKING, BUT NOT UNEDITED GluA2-CONTAINING,
AMPA RECEPTORS ARE KNOWN TO PLAY A ROLE IN ENHANCING
SYNAPTIC PLASTICITY
We will only brieﬂy touch on the role of GluA2-lacking recep-
tors in this review for the purpose of noting that this form of
Ca2+-permeable AMPA receptors are critical in brain function
(Cull-Candy et al., 2006; Isaac et al., 2007; Liu and Zukin, 2007;
Man, 2011). While there is no known role of unedited GluA2
in normal brain function, there is now thought to be a role for
GluA2-lacking AMPA receptors. GluA2-lacking AMPA receptors
offer an alternative route to NMDA receptors for Ca2+ ﬂux into
cells at synapses and are now recognized to play an important role
in synaptic plasticity by triggering LTP (Jia et al., 1996; Harvery
et al., 2001; Meng et al., 2003; Lu et al., 2007; Asrar et al., 2009;
Wiltgen et al., 2010). Notably however, the properties of AMPA
receptor-mediated LTP is different to NMDA receptor-mediated
LTP (Lamsa et al., 2007; Kullmann and Lamsa, 2008).
Due to their distinct physiological effects, GluA2-lacking
receptors have recently been discovered to be important in learn-
ing and memory. Wiltgen et al. (2010) showed that NMDA
receptor-independent learning was not impaired in mice with
a selective GluA2 KO in the CA1 region of the hippocampus.
However, by blocking Ca2+-permeable AMPA receptors dur-
ing an NMDA receptor-independent learning process, NMDA
receptor-independent learning was signiﬁcantly impaired (Wilt-
gen et al., 2010). Further, Clem and Barth (2006) demonstrated
that evoked activity of a single spared whisker (after removal of
the others) increases the trafﬁcking of GluA2-lacking receptors
into the barrel column of the spared whisker, suggesting that a
sensory experience can increase Ca2+-permeable AMPA recep-
tors and strengthen neocortical excitatory synapses (Clem and
Barth, 2006). In addition, GluA2-lacking receptors are increased
in the ventral tegmental area of mice following a single injection of
cocaine and are thought to contribute to cocaine-evoked plasticity
(Bellone and Luscher, 2006), thus contributing to time depen-
dent seeking of cocaine following self administration (Conrad
et al., 2008). These studies suggest that GluA2-lacking recep-
tors may be involved in synaptic strengthening and are essential
for NMDA receptor-independent learning and processes in the
healthy brain.
As noted above, it has generally been concluded that the occur-
rence of Ca2+-permeable receptors results from the presence of
GluA2-lacking receptors, rather than unedited GluA2. It is plausi-
ble, however, that like GluA2-lacking receptors, there may indeed
be a role for unedited GluA2 in brain processes such as LTP and
LTD that has not yet been determined. As we will now show,
however, while the role of unedited GluA2 in the healthy brain
remains unknown, recent evidence suggests that GluA2 RNA edit-
ing is essential for survival and unedited GluA2 plays an important
role in neuronal loss in certain diseases.
MICE ENGINEERED WITH GluA2 MUTATIONS REVEAL AMPA
RECEPTORS CONTAINING UNEDITED GluA2 HAVE DISTINCT
PHYSIOLOGICAL EFFECTS
While GluA2-lacking receptors appear to have a role in synaptic
plasticity, unedited GluA2 receptors have a fundamentally differ-
ent physiological effect. Mice in which GluA2 is ablated (GluA2
KO mice) have Ca2+-permeable AMPA receptors made up of the
GluA1, GluA3, and GluA4 subunits. These mice are viable, and
live to an old age, suggesting that the presence of Ca2+-permeable
AMPA receptors may not be intrinsically excitotoxic. In contrast,
mice engineered with reduced RNA editing show a profoundly
different phenotype. Brusa et al. (1995) engineered mice in which
the ECS is replaced with a loxP sequence (GluA2ECS/+ mice).
The lack of the ECS in the intron means GluA2 Q/R RNA editing
was impaired. This resulted in approximately 25%uneditedGluA2
mRNA at the Q/R site compared to age-matched wild-type litter-
mates, which have almost no unedited GluA2 mRNA. In contrast
to Ca2+-permeable AMPA receptors in GluA2 KO mice (Jia et al.,
1996; Sans et al., 2003; Wiltgen et al., 2010), the presence of an
increased number of unedited GluA2 containing AMPA receptors
in mice lead to seizures and premature death by several weeks of
age (Brusa et al., 1995).
In addition to the GluA2ECS/+ mice engineered by Brusa
et al. (1995), Feldmeyer et al. (1999) developed mice with vary-
ing degrees of GluA2Q/R RNA editing. These mice included
the GluA2ECS/+ mouse, and an additional strain in which the
loxP-ﬂanked neomycin gene was left in the gene, replacing the
ECS site (GluA2neo/neo). The practical result of this was that
the most unedited GluA2 RNA was observed in GluA2neo/neo
(98% unedited GluA2 mRNA), slightly less was observed in
GluA2ECS/+ mice (∼27% unedited GluA2 mRNA) and less
again was observed in GluA2+/neo mice (8.7% unedited GluA2
mRNA). The reduced editing efﬁciency in each of the mice strains
correlated with the Ca2+-permeability of the AMPA receptor
and the phenotype. GluA2neo/neo which expressed 98% unedited
GluA2(Q) mRNA showed severe dendritic deﬁcits and early death
by postnatal day 20. In comparison, GluA2neo/+ mice had 8.7%
expression of GluA2(Q), showing less dramatic increases inAMPA
receptor Ca2+-permeability and a 20% death rate (Feldmeyer
et al., 1999).
Recent studies have indicated that the lethality of the unedited
GluA2(Q) subunitmaybedue to aGluA2–NSF interaction (Maha-
jan and Ziff, 2007). Thus, alteration to GluA2 RNA editing
efﬁciency has detrimental effects, and the extent of this effect
is dependent upon the percentage of unedited GluA2(Q) RNA
expressed, highlighting the absolute requirement for GluA2 RNA
editing in synaptic function.
Although reducing RNA editing efﬁciency results in lethality,
the unedited GluA2 is not essential for survival. Kask et al. (1998)
used gene targeting to generate mice in which the codon for Arg
was encoded in the GluA2 gene (GluA2R/R). These mice are essen-
tially “forced-edited” as the Arg is encoded in the exon and there
is no requirement for RNA editing to post-transcriptionally alter
GluA2 at the Q/R site, therefore there is no GluA2(Q) present
in these mice. The authors noted that these GluA2R/R mice are
fundamentally normal with no obvious deﬁciencies. This suggests
that there is no essential functional requirement of the GluA2 Gln
allele and it is still unclear as to why RNA editing occurs in the
normal brain as opposed to exon coding of the codon for Arg.
As described earlier, ADAR2 is essential for GluA2 RNA
editing. Interestingly, mice engineered with ADAR2 ablation
(ADAR2−/−; Higuchi et al., 2000) are phenotypically compara-
ble to GluA2ECS/+ mice (Brusa et al., 1995). ADAR2−/− mice
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show fully unedited GluA2 and display a 30-fold increase in Ca2+-
permeability of AMPA receptors, resulting in lethality at just
several weeks of age (Higuchi et al., 2000). In addition, knockdown
of hippocampalADAR2 levels using viral vectors expressing siRNA
increasedCa2+-permeability of AMPAreceptors by approximately
15-fold and increased cell death (Peng et al., 2006).
Notably, when ADAR2−/− mice were crossed with GluA2R/R
mice, the lethal phenotype observed in the ADAR2−/− mice was
rescued, and survival rates were signiﬁcantly increased to several
months of age (Higuchi et al., 2000). Therefore, if the GluA2 gene
is artiﬁcially “forced-edited,” then ADAR2 is no longer essential
for survival. This remarkable experiment revealed that ADAR2 is
essential for survival because of its role in editing GluA2 at the
Q/R site. Thus, although other roles have been explored (Horsch
et al., 2011), it appears that RNA editing at the Q/R site of GluA2
is the essential target substrate of ADAR2.
Combined, the aforementioned studies make it clear that alter-
ation to the RNA editing, by modifying the ECS or by ablation of
ADAR2 is detrimental to cell survival, leading to the hypothesis
that these mechanisms could possibly contribute to excitotoxic-
ity in disease. Perhaps, the most important conclusion that can
be drawn from these outstanding studies is that unedited GluA2,
when expressed in a neuron, will be expressed at synapses and will
have a functional effect.
A POSSIBLE ROLE FOR GluA2 EDITING?
Given its importance for regulating Ca2+ inﬂux, it might be
expected that Q/R site RNA editing in GluA2 would be an
exquisitely regulated process in the normal CNS. Surprisingly,
however, it has been accepted for many years that theAMPA recep-
tor subunit GluA2 in its Q/R site-unedited form is not essential for
brain development and function (Higuchi et al., 1993; Kask et al.,
1998). Indeed, uneditedGluA2 at theQ/R site accounts for<1%of
GluA2mRNA in the normal brainwhereGluA2 is present. Despite
this, GluA2 Q/R site editing occurs in mammals, amphibians, and
some species of ﬁsh (Kung et al., 2001), suggesting that GluA2 Q/R
site RNA editing is evolutionarily conserved. This raises the signif-
icant question as to why a complicated process like RNA editing
has evolved to convert a CAG codon encoding Gln in the gene
into a CGG codon encoding Arg in the mRNA, as opposed to
simply encoding the CGG codon for Arg in the GluA2 gene. A
clue to the answer may lie in the observation that the efﬁciency of
RNA editing varies between certain brain regions and may differ
between speciﬁc cells (Nutt and Kamboj, 1994; Kawahara et al.,
2003, 2004a; Peng et al., 2006). This raises the tantalizing possibil-
ity that unedited GluA2 RNA may have a role in certain regions in
the CNS. Thus, the question still remains as to what role unedited
GluA2 plays in the normal functioning brain.
NOVEL INSIGHTS INTO THE IMPORTANCE AND REGULATION
OF GluA2Q/R SITE RNA EDITING
It is clear that ADAR2 depletion and reduced editing can
cause catastrophic downstream effects. What is not understood,
however, is why such a complex RNA editing mechanism occurs
in neurons. In addressing this question, it should be taken into
consideration that although it is often stated that there is on aver-
age ∼1% of unedited GluA2 in the adult, it is feasible that editing
is temporally and spatially regulated, potentially even varying
between individual neurons.
It is now established that ADAR2 expression is regulated, sug-
gesting in turn that GluA2 RNA editing may be regulated. For
example, ADAR2 expression is modulated during development
and is only expressed within the thalamic nuclei in the fetal brain
(Paupard et al., 1999) and expression levels increase gradually over
time (Jacobs et al., 2009). In addition to this, studies have shown
that human neural progenitor cells (Whitney et al., 2008; Jans-
son et al., 2011), and malignant gliomas (Maas et al., 2001), are
Ca2+-permeable and express unedited GluA2. These studies give
indication that unedited GluA2 may play a role in cell function,
even though the process is not essential for survival (Higuchi
et al., 1993; Kask et al., 1998). Further research is required to
understand the need for RNA editing of GluA2 in order to deter-
mine if, how, and why it is modulated in the normal brain and
in disease.
GluA2 RNA EDITING HAS A ROLE IN AMPA RECEPTOR
TRAFFICKING
While it is well established that the GluA2 subunit regulates
trafﬁcking (discussed in Section “The GluA2 Subunit Regu-
lates Calcium Permeability and Trafﬁcking of AMPA Receptors”),
GluA2 RNA editing has also been shown to be involved in AMPA
receptor trafﬁcking. It is known that a signiﬁcant proportion of
edited GluA2 remains in the ER before being trafﬁcked to the
synapse (Greger et al., 2002). In addition, the rate of direct inser-
tion of edited GluA2 into the membrane is lower than that of
unedited GluA2. This insertion of unedited GluA2, in conjunc-
tionwith theNSFbinding site present on theC-terminus of GluA2,
accelerates the insertion into the membrane (Araki et al., 2010). In
contrast, edited GluA2 at the Q/R site forms a more stable pool
of the subunit in the ER that is stored for later AMPA receptor
formation. In addition, GluA2 RNA editing at the Q/R site also
plays a role in AMPA receptor tetramerization as edited GluA2
preferentially form dimers (Greger et al., 2003). In the absence of
GluA2 Q/R RNA editing, hetero and homotetramers are formed
and are rapidly trafﬁcked from the ER to the plasma membrane.
This is, however, also dependent upon the editing at the R/G site
(Greger et al., 2007). When editing occurs at the Q/R site, but is
not present at the R/G site, GluA2 subunits are more likely to
tetramerize (Greger et al., 2006). Thus, in the presence of unedited
GluA2, Ca2+-permeable AMPA receptors are potentially incorpo-
rated into the synapse, permitting an inﬂux of Ca2+ ions, although
more studies are required. If so, it is possible that even though there
is only ∼1% of GluA2 present, there is a disproportionate effect
on AMPA receptor Ca2+-permeability.
GluA2 is typically rapidly transported to the synapse when
unedited GluA2 forms heterotetramers with GluA3 and interacts
with NSF. This could potentially lead to excessive Ca2+ inﬂux in
the diseased brain. Mahajan and Ziff (2007) showed that the addi-
tion of a peptide, pep2m, blocks the interaction between NSF and
the heterotetramer and, thus, reduces the toxicity to the cell in
vitro. Though this has yet to be studied in vivo, the results suggest
that interfering with the interaction of unedited GluA2 with other
proteins may regulate unedited GluA2 mediated excitotoxicity. If
true, then interfering with such interactions may act as a viable
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treatment for diseases associated with low GluA2 editing efﬁciency
(Mahajan and Ziff, 2007).
REGULATION OF GluA2 RNA EDITING
The molecular mechanisms that regulate GluA2 RNA editing
are beginning to emerge. Peng et al. (2006) showed that altered
cAMP response element-binding (CREB)-transcriptional regu-
lation leads to a reduction in ADAR2 expression. By virally
expressing CREB following transient global ischemia, ADAR2
production was restored, thereby increasing GluA2Q/R RNA edit-
ing back to levels over 90%. This study was the ﬁrst to give a
mechanism by which GluA2 RNA editing deﬁciencies occur in
the diseased brain. More recently, other transcriptional regula-
tors have been shown to play a role in ADAR2 expression. In the
absence of peptidyl-prolyl isomerase NIMA interacting protein 1
(Pin1), which is responsible for phosphorylation of ser/thr-pro
motifs, editing efﬁciency at the Q/R site is reduced (Marcucci
et al., 2011). By co-transfecting a plasmid encoding ADAR2 with
a GluA2 minigene, an RNA editing level of 100% was achieved.
However, when Pin1 was blocked by siRNA, the editing efﬁciency
dramatically fell to 53%. Similar levels of Q/R site editingwere seen
when co-transfectionwas conductedwith theGluA2minigene and
ADAR2 into immortalized mouse ﬁbroblast cell lines derived from
Pin1−/− mice. In addition, the mislocalization of ADAR2 in the
absence of Pin1 also reduces editing at the R/G site highlighting the
necessity of ADAR2 for editing at this site. Further, in the absence
of Pin1 the authors observed the mislocalization of ADAR2 into
the cytoplasm, rendering it unable to efﬁciently edit GluA2 (Mar-
cucci et al., 2011). Within the cytoplasm WWP2, which possesses
ubiquitin-protein ligase activity, is able to degrade ADAR2 and
is therefore a negative regulator of the protein (Marcucci et al.,
2011). These sophisticated studies show that there is regulation
of ADAR2 and raise signiﬁcant excitement about the potential for
understanding the regulation of RNA editing.
EXCITOTOXICITY IS DETRIMENTAL TO THE EFFICIENCY OF GluA2
RNA EDITING
ADAR2 degradation would be expected to play a role in many
diseases where Q/R site editing is compromised. Mahajan et al.
(2011) have demonstrated that high concentrations of gluta-
mate can activate processes which induces cleavage of the ADAR2
enzyme in vitro. This glutamate-induced cleavage is both dose-
and time-dependent and is reliant upon the activation of NMDA
receptors. However, when calpain inhibitors were applied to
glutamate-stimulated neurons that virally express ADAR2, no
cleavage of the enzyme was observed. Proteasome inhibitors
and caspase inhibitors were unable to prevent ADAR2 degra-
dation thus proving calpain mediates ADAR2 cleavage when
in the presence of excessive glutamate (Mahajan et al., 2011).
Furthermore, calpain inhibitors have been shown to have neu-
roprotective effects in ischemia (Bartus et al., 1994) and thus
suggest a potential therapeutic target for other GluA2 RNA edit-
ing deﬁcient disorders. By showing that glutamate, which is
deregulated in many diseases, can induce cleavage of ADAR2,
Mahajan et al. (2011) has provided insights into a direct mech-
anism in which neurological catastrophes may potentially cause
GluA2 RNA editing deﬁciencies.
AMPA RECEPTORS ARE INVOLVED IN EXCITOTOXIC
NEURONAL DEATH IN DISEASE
DOWNREGULATION OF GluA2 OCCURS IN DISEASE
It has long been known that neuronal death escalates disease
progression in ALS and ischemia (reviewed in Doble, 1999).
AMPA receptors lacking GluA2 are highly permeable to Ca2+,
and many early studies suggested that they might potentially
contribute to Ca2+-mediated excitotoxic cell death in disease.
Known as the “GluA2 hypothesis” (Pellegrini-Giampietro et al.,
1997), this theory suggests that neurological insults potentially
decrease the expression of GluA2, resulting in many AMPA
receptors that are highly permeable to Ca2+. This process
consequently may contribute to neurodegeneration in disease
(Pellegrini-Giampietro et al., 1997; Tanaka et al., 2000).
GluA2 gene downregulation results in formation of AMPA
receptors lacking GluA2. Hippocampal cells normally express
GluA2, and changes in expression levels may have effects on
the Ca2+-permeability of AMPA receptors. It has been shown
that 24–72 h following ischemic insult, GluA2 protein is down-
regulated, particularly in the CA1 region of the hippocampus
where cell death is abundant (Pellegrini-Giampietro et al., 1992).
The internalization of AMPA receptors following oxygen–glucose
deprivation, a model of ischemia, has been shown to lead to a
subsequent delivery of Ca2+-permeable AMPA receptors to the
synapse (Liu et al., 2006). This process is regulated by the gene
silencing transcription factor neuronal repressor element-1 silenc-
ing transcription factor (REST; Calderone et al., 2003). Global
ischemia increases REST mRNA expression in the CA1 region of
the hippocampus, which in turn suppresses GluA2 gene expres-
sion. In addition, the suppression of REST expression by the use of
antisense oligodeoxynucleotides increased neuronal survival 72 h
post oxygen–glucose deprivation (Calderone et al., 2003).
While these Ca2+-permeable AMPA receptors observed in
the ischemic brain appear to be in part GluA2-lacking (due to
down regulation of GluA2; Pellegrini-Giampietro et al., 1992)
recent evidence suggests they may also result from the presence
of unedited GluA2 (see GluA2Q/R RNA Editing Deﬁciencies
Occur in Ischemia). These Ca2+-permeable AMPA receptors,
when in the diseased state, potentially contribute to excitotoxi-
city, despite such receptors also being required for maintenance
of synaptic plasticity. This is analogous to NMDA receptor-
mediated excitotoxicity, whereby a normal Ca2+-permeable
receptor that is essential to synaptic plasticity is also critically
implicated in excitotoxic cell death (reviewed in Hardingham and
Badling, 2003).
MODULATION OF GluA2 RNA EDITING AT THE Q/R SITE HAS
IMPLICATIONS FOR SURVIVAL
Through elegant studies, it is now known that modiﬁcations
to RNA editing at the Q/R site can lead to effects on synaptic
and cellular physiology and can lead to neuronal cell loss (Brusa
et al., 1995; Kawahara et al., 2004b; Peng et al., 2006). As noted
above, GluA2ECS/+ mice have altered editing efﬁciency and thus
increased AMPA receptor Ca2+-permeability leading to sponta-
neous seizures and cell loss within the hippocampus and death
by postnatal day 20 (Brusa et al., 1995; Feldmeyer et al., 1999).
Whether, by inference, unedited GluA2 plays a role in human
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epilepsy is not clear. Unedited GluA2 was not found in the hip-
pocampus and temporal cortex of epileptic patients (Kortenbruck
et al., 2001). Thismay be due to the difﬁculty of detecting unedited
RNA in disease (Kawahara et al., 2004a; Peng et al., 2006). Thus,
as our current knowledge is limited, further studies using individ-
ual cell based assays are required to elucidate the role of GluA2
editing in epilepsy. Similarly, the editing mutant mice raise the
possibility, but do not prove that, unedited GluA2 is important
in any human disease. The most important point to be taken
from the elegant study conducted by Brusa et al. (1995) is that
unedited GluA2 can have critical functional effects on cellular
physiology.
GluA2Q/R RNA EDITING DEFICIENCIES OCCUR IN AMYOTROPHIC
LATERAL SCLEROSIS
As noted above, it has been suggested that Ca2+-permeable AMPA
receptors resulting from GluA2 downregulation occurs in various
neurological diseases such as ischemia and epilepsy (Pellegrini-
Giampietro et al., 1992; Pollard et al., 1993; Gorter et al., 1997).
In addition, reduced GluA2 Q/R site RNA editing also results
in formation of Ca2+-permeable GluA2(Q)-containing AMPA
receptors in ischemia. Historically, numerous attempts were made
to identify unedited GluA2 RNA and little, if any, was ever found
to be present in both the healthy and diseased brain (Akbarian
et al., 1995; Rump et al., 1996; Kortenbruck et al., 2001). This led
to the widely held concept that the presence or absence of the
GluA2 subunit, rather than RNA editing, is the main process for
regulating Ca2+-permeability of AMPA receptors in disease. As
such, the role of unedited GluA2 in many neurological disorders
has never been investigated on a cellular level as was recently done
for ischemia (Peng et al., 2006).
RNA editing deﬁcits have been shown in motor neurons of
patients with ALS (Takuma et al., 1999; Kawahara et al., 2004a).
No alteration to GluA2 mRNA expression was observed, however,
spinal motor neurons showed a GluA2 RNA editing efﬁciency
ranging from 0 to 100% in individual neurons (Kawahara et al.,
2004a). Within the same patients, GluA2 RNA editing in Purkinje
cells were unaltered, indicating that the deﬁciency is motor neuron
speciﬁc. While the work by Kawahara et al. (2004a) does not prove
that unedited GluA2 is a cause of cell loss in ALS, the results are
highly important when put in the context of the work conducted
by Brusa et al. (1995) and Feldmeyer et al. (1999), which showed
that the process of RNA editing at the GluA2Q/R site is essential
for cell survival.
It is perhaps interesting, however, in mice transgenic for
mutant human Cu/Zn-superoxide dismutase (SOD1), a clas-
sic model of familial ALS, RNA editing deﬁciencies at the Q/R
site were not observed (Kawahara et al., 2006). This highlights
the possibility that mouse models of ALS may not fundamen-
tally represent the human disease pathogenesis, and/or suggests
unedited GluA2 mRNA at the Q/R site is not needed for the
ALS phenotype. Despite this, studies have shown that cross-
ing SOD1 mice with mice that express Ca2+-permeable AMPA
receptors (generated by inserting an asparagine codon at the
Q/R site) accelerates motor deterioration and disease onset when
compared to age-matched SOD1 mice (Kuner et al., 2005). It
is likely that GluA2 RNA editing deﬁciencies occur in ALS
due to the downregulation of ADAR2, which has decreased
expression in the spinal cords of patients with sporadic ALS
(Kawahara and Kwak, 2005; Hideyama et al., 2010). In fact,
the ablation of ADAR2 expression in mice results in a phe-
notype very similar to ALS patients including the progressive
death of motor neurons and a decline in motor function
(Hideyama et al., 2010). ADAR2 downregulation in ALS cor-
relates with phosphorylated TDP-43, an RNA binding protein
whose mutations are associated with ALS (Aizawa et al., 2010).
These studies could suggest that GluA2 RNA editing deﬁciencies
may be an important event in ALS, though the cellular mech-
anisms that regulate RNA editing deﬁciencies in ALS remain
unsolved.
GluA2Q/R RNA EDITING DEFICIENCIES OCCUR IN ISCHEMIA
While it is evident that GluA2 mRNA downregulation occurs in
ischemia (seeDownregulation of GluA2Occurs inDisease), recent
evidence has indicated that GluA2 RNA editing deﬁciencies also
occur in ischemia. In a model of transient global ischemia, GluA2
RNA editing efﬁciency of individual neurons at the Q/R site in
the CA1 region of the hippocampus is dramatically decreased
(Peng et al., 2006). Using electrophysiology and single cell RT-
PCR, the authors correlated the GluA2 RNA editing efﬁciency of
individual neurons to their Ca2+-permeability. RNA editing at
the Q/R site showed extremely high variability (7–98%) in edit-
ing efﬁciency following ischemic insult within neurons of the
CA1 region of the hippocampus. This editing efﬁciency corre-
lated closely to the Ca2+-permeability of the neurons. Neither
cell death nor GluA2 RNA editing deﬁciencies were seen in the
CA3 region, indicating the CA1 region is most vulnerable to
editing changes and ischemic insult. Interestingly, this cellular
death closely correlates with the downregulation of ADAR2 (Peng
et al., 2006). The authors demonstrated that by virally mediated
expression of ADAR2 in vivo, the RNA editing efﬁciency at the
GluA2Q/R site was adequately enhanced to over 95% post the
ischemic insult and consequently lead to neuroprotection. These
experiments provide substantial evidence that GluA2 RNA editing
plays a vital role in mediating excitotoxic neuronal death during
ischemia.
Since Ca2+-permeable AMPA receptors appear to occur due
to the presence of unedited GluA2 and also from GluA2-lacking
receptors in ischemia, the question arises as to which of these two
types of AMPA receptors are expressed at the synapse and if only
one type, or both, contributes to cell death. Given the astonishing
results byPeng et al. (2006),which showed that the over-expression
of ADAR2 is able to rescue cell loss following ischemic insult, it
is possible that despite GluA2-lacking receptors being present, the
unedited GluA2 is critical for cell death, as previously mentioned
in Section “Novel Insights into the Importance and Regulation of
GluA2Q/R RNA Editing.”
NEUROPROTECTIVE MECHANISMS FOR CALCIUM-MEDIATED
EXCITOTOXICITY
Currently, the primary treatments to prevent against Ca2+-
mediated neurotoxicity involve NMDA receptor antagonists. The
beneﬁcial effects are less than ideal and in addition there are often
side effects, possibly due to blocking the physiological actions
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of glutamate neurotransmission and plasticity in non-injured
neurons (reviewed in Parsons et al., 2007). Studies have also sug-
gested, however, that blocking Ca2+-permeable AMPA receptors
in animal models of ischemia can protect against cell death in
vulnerable neurons. When given intraperitoneal injections of the
AMPA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione (NBQX) following transient fore-
brain ischemia, cell survival within the CA1 region was signif-
icantly increased (Buchan et al., 1991). In addition, 1-naphthyl
acetyl spermine (Naspm), which blocks GluA2-lacking and
unedited GluA2 containing AMPA receptors, exerts neuroprotec-
tive effects. Noh et al. (2005) demonstrated that by administering
Naspm to mice 9–40 h postischemic injury, there is increased
cell survival within the CA1 region. These studies demonstrate
that Ca2+-permeable AMPA receptors play a role in modulat-
ing cell death and show antagonists to AMPA can protect against
cell loss in ischemia. An important idea, given the evidence in
ischemia for example, is whether more effort is needed to block
altered RNA editing in order to protect against excitotoxicity
in disease.
CONCLUSION
Little consideration has been given to what role the evolutionarily
conserved process of GluA2 RNA editing may play in nor-
mal brain function. Many early studies suggested that unedited
GluA2 exists at very low levels in the brain and that the extent
of unedited GluA2 is not altered substantially in most diseases
where editing was investigated (Akbarian et al., 1995; Rump et al.,
1996; Kortenbruck et al., 2001). Taken together, the evidence has
been compelling that unedited GluA2 does not play a major
role in brain function. However with some notable exceptions,
few recent studies have probed the role of unedited GluA2 in
disease (Kawahara et al., 2004a; Peng et al., 2006). We there-
fore suggest that it is not yet possible to exclude the possibility
that unedited GluA2 also contribute to the presence of Ca2+-
permeable AMPA receptors in normal brain function, such as
synaptic plasticity.
The blockade of Ca2+-permeable AMPA receptors is known
to improve cell survival in diseased states, however the extent to
which uneditedGluA2 contributes to excitotoxic neurondeath still
needs to be elucidated. Sophisticated approaches recently revealed
a possible role for unedited GluA2 in ischemia and ALS, despite
previous studies ruling out a role for unedited GluA2 in ischemia
(Kawahara et al., 2004a; Peng et al., 2006). By extension, the lack
of evidence for extensive unedited GluA2 in other scenarios so
far investigated does not rule out a role for unedited GluA2 in
normal physiology or disease. Evidence that unedited GluA2 is
preferentially trafﬁcked to the cell surface is important because it
adds weight to the view that small amounts of unedited GluA2
can have an impact on normal neuronal function (Greger et al.,
2002, 2003, 2007). Furthermore, mice engineered with unedited
GluA2 to date reveal that unedited GluA2 can have an important
effect on cellular physiology and cell survival (Brusa et al., 1995;
Feldmeyer et al., 1999). Taken together, it is clear that while the
average amount of unedited GluA2 is always very low, it can vary
between cells with functional consequences.
In conclusion, we suggest that the presence of unedited GluA2,
in addition to GluA2-lacking receptors, should be considered as
a possibility in studies where Ca2+-permeable AMPA receptors
are described or observed. Numerous studies show that Ca2+-
permeable receptors are critical in normal brain function and
disease. Studies are essential to determine the extent to which both
unedited GluA2 and GluA2-lackingAMPA receptors contribute in
these circumstances.
Exciting recent studies have indicated that ADAR2 is down-
regulated in disease, concomitant with reduced RNA editing.
Mechanisms in which ADAR2 expression is regulated are now
being investigated and the complex pathways involved in GluA2
RNA editing are being increasingly unraveled. This emerging
knowledge may aid in understanding the regulation and func-
tional role of GluA2 Q/R RNA editing. It is possible that such
studies in future may reveal that the ∼1% unedited GluA2 found
in themammalian brainmay have as-yet unknown role in synaptic
plasticity and disease.
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